Genesis Innovation Group
9
4M
6
1.00
3
0.33
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the Missoula. The company was established in North America in United States.
Considering the real fund results, this Corporate Investor is 80 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2018.
The fund has exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Advanced Materials. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Shoulder Innovations, Embody
This organization was formed by Don Running.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Genesis Innovation Group, startups are often financed by Michigan Angel Fund, Dreamit Ventures, CIT GAP Funds. The meaningful sponsors for the fund in investment in the same round are Wakestream Ventures, cultivate(MD), PrairieGold Venture Partners. In the next rounds fund is usually obtained by cultivate(MD).
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 3
- Rounds per year
- 1.00
- Follow on index
- 0.33
- Investments by industry
- Health Care (6)
- Medical Device (6)
- Biotechnology (4)
- Information Technology (4)
- Advanced Materials (3) Show 7 more
- Investments by region
-
- United States (9)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.56
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Embody | 20 Sep 2022 | Biotechnology, Medical Device, Medical | Late Stage Venture | 10M | United States, Virginia, Norfolk |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.